Donor Site Morbidity After Free Vascularized Fibular Graft
- Sponsor
- Assiut University
- Study ID
- NCT06324916
- Status
- Recruiting
Conditions
- Osteosarcoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Xray — RADIATIONX rays for ankle to see distal fibular remenant
Study Details
This study was carried out at Assiut University to Asses the long-term donor site morbidity following free vascularized fibular transfer because there is a limited information regarding the long-term donor morbidity of this type of flap.
Key Dates
- First listed
- Mar 22, 2024
- Start date
- Jan 10, 2024
- Status verified
- Mar 2024
- Primary completion
- Jan 10, 2026
- Completion
- Dec 30, 2026
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Donor site morbidity in contrast with surgery benifits this will be measured by point evaluation system [ Time Frame: Two years after surgery ]
Central Contacts
- Hedra Rafat Ishak00201069557727
Related Studies
- Clinical Orthopaedic Data Bank (Acute and Chronic)Recruiting · University of Florida · Gainesville, Florida
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruiting · Children's Oncology Group · Birmingham, Alabama
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsPHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- Assessment of Healing and Function After Reconstruction Surgery for Bone SarcomasRecruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey